Title : Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.

Pub. Date : 2009 Aug

PMID : 19491661






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In conclusion, YSL significantly inhibited the growth of human hepatocellular carcinoma BEL-7402 cells and its anti-tumor effects may result from the upregulation of cyclin P21 and P27, and downregulation of cyclin PCNA. H-Tyr-Ser-Leu-OH interferon alpha inducible protein 27 Homo sapiens